国产在线一区二区三区av-裸体丰满白嫩大尺度尤物-日本成本人三级在线观看-91亚洲精品在线观看-天天操欧美-欧美日韩综合一区二区-黑人操欧美人-国产日韩91-在线观看 亚洲-神马午夜嘿嘿-亚洲www色-一级黄色片欧美-精品一区二区三区四-日韩人妻无码精品久久久不卡-久久免费看少妇高潮v片特黄-日本三级网站在线观看-欧美老熟妇乱大交xxxxx-av性色av久久无码ai换脸-国产凸凹视频一区二区-久久久久国产精品人妻aⅴ四季

Technoderma Medicines, Inc.is a clinical stage biopharmaceutical company.

The company's current core research and development programs include innovative drugs for the treatment of androgenic alopecia, eczema/atopic dermatitis, psoriasis and lupus. TDM-105795, the world's leading small-molecule drug candidate for the treatment of androgenic alopecia, has now completed 2a clinical trials. TDM-180935, a novel JAK1/TYK2 inhibitor for eczema/atopic dermatitis, has also completed a Phase 1 clinical trial in December 2023 with favorable safety results, and Phase 2 a POC clinical trials are underway in the United States.